6 research outputs found
Table_1_Association between urinary organophosphate ester metabolite exposure and thyroid disease risk among US adults: National Health and Nutrition Examination Survey 2011-2014.docx
BackgroundOrganophosphate esters (OPEs) may interfere with thyroid function, but the relationship between OPEs and thyroid disease remains unclear. This study aims to elucidate the relationship between OPEs exposure and thyroid disease risk in the general population in the United States.MethodData were obtained from the 2011-2014 National Health and Nutrition Examination Survey cycle. All participants were tested for seven OPE metabolites in their urine and answered questions about whether they had thyroid disease through questionnaires. Logistic regression was employed to analyze the association between exposure to individual OPE metabolites and thyroid disease. Weighted Quantile Sum (WQS) regression modeling was utilized to assess exposure to mixed OPE metabolites and risk of thyroid disease. Bayesian kernel machine regression(BKMR) models to analyze the overall mixed effect of OPE metabolites.ResultA total of 2,449 participants were included in the study, 228 of whom had a history of thyroid disease. Bis(1,3-dichloro-2-propyl) phos (BDCPP), Diphenyl phosphate (DPHP) and Bis(2-chloroethyl) phosphate (BCEP) were the top three metabolites with the highest detection rates of 91.75%, 90.77% and 86.57%, respectively. In multivariate logistic regression models, after adjustment for confounding variables, individuals with the highest tertile level of BCEP were significantly and positively associated with increased risk of thyroid disease (OR=1.57, 95% CI=1.04-2.36), using the lowest tertile level as reference. In the positive WQS regression model, after correcting for confounding variables, mixed exposure to OPE metabolites was significantly positively associated with increased risk of thyroid disease (OR=1.03, 95% CI=1.01-1.06), with BCEP and DPHP having high weights. In the BKMR model, the overall effect of mixed exposure to OPE metabolites was not statistically significant, but univariate exposure response trends showed that the risk of thyroid disease decreased and then increased as BCEP exposure levels increased.ConclusionThe study revealed a significant association between exposure to OPE metabolites and an increased risk of thyroid disease, with BCEP emerging as the primary contributor. The risk of thyroid disease exhibits a J-shaped pattern, whereby the risk initially decreases and subsequently increases with rising levels of BCEP exposure. Additional studies are required to validate the association between OPEs and thyroid diseases.</p
Table_1_The role of rare earth elements and dietary intake in tongue cancer: a mediation analysis in southeast China.DOCX
ObjectiveThe current research aimed to examine how dietary intake and rare earth elements may affect the development of tongue cancer.MethodsThe serum levels of 10 rare earth elements (REEs) in 171 cases and 171 healthy matched controls were measured by inductively coupled plasma mass spectrometry (ICP-MS). The conditional logistic regression was used to examine the relationship between dietary intake, serum levels of 10 REEs, and tongue cancer. Mediation effect and multiplicative interaction analysis were then performed to estimate the potential contribution of REEs in dietary intake associated with tongue cancer.ResultsCompared with the control group, patients with tongue cancer consumed significantly less fish, seafood, fruit, green leafy vegetables, and non-green leafy vegetables, with higher serum praseodymium (Pr), dysprosium (Dy), and lanthanum (La) levels, and lower serum cerium (Ce) and scandium (Sc) levels. The interaction effect was observed between some REEs and food categories. Green vegetables' impact on the risk of tongue cancer is partially attributed to the La and Thorium (Th) elements (P ConclusionThe correlation between REEs and dietary intakes for tongue cancer is compact but intricate. Some REEs interact with food intake to influence tongue cancer, while others act as a mediator.</p
Outcomes of subgroup analyses by sex and diabetes status.
<p>*For interaction.</p><p>Outcomes of subgroup analyses by sex and diabetes status.</p
Flow chart of articles selection for this systematic review and meta-analysis.
<p>Flow chart of articles selection for this systematic review and meta-analysis.</p
Meta-regression between male percentage and the effects of aspirin on risk of MI or stroke.
<p>(A) Log relative risk of stroke in relation to male percentage in all people. (B) Log relative risk of MI in relation to male percentage in diabetic patients. (C) Log relative risk of stroke in relation to male percentage in diabetic patients. The gray bonds in each figure are confidence interval. The size of the bubble represents the value of the weight. MI = myocardial infarction.</p
Design of trials included in the meta-analysis.
<p>*Median year follow-up.</p><p>PHS = Physicians Health Study. BDT = British Doctor's Trial. TPT = Thrombosis Prevention Trial. HOT = Hypertension Optimal Treatment trial. PPP = Primary Prevention Project.WHS = Women's Health Study. POPADAD = Prevention of Progression of Arterial Disease and Diabetes trial. JPAD = Japanese primary Prevention of Atherosclerosis with Aspirin for Diabetes trial. AAA = Aspirin for Asymptomatic Atherosclerosis trial. ETDRS = the Early Treatment Diabetic Retinopathy Study. APLASA = Antiphospholipid Antibody Acetyl-salicylic Acid study. ECLAP = European Collaboration on Low-Dose Aspirin in Polycythemia Vera study. CLIPS = Critical Leg Ischaemia Prevention Study. ACBS = Asymptomatic Cervical Bruit Study.</p><p>MCEs = major cardiovascular events; MI = myocardial infarction.</p><p>Design of trials included in the meta-analysis.</p